alzheimer's disease. now researchers have identified more than 70 associated genetic areas opening multiple new avenues for potential prevention and treatments. there is another point that helps put this into perspective. in the early 2000'sthe only sure way to know whether a person had alzheimer's was through an yoautposy, since the there's been imagining techniques, biomarker tests and more precise and earlier. are and there have been disease modified therapies targeting plaques. the national alzheimer's project act law is scheduled to expire soon. we must reauthorize the law to make sure that investments remain coordinated to maximize their impact. toward that end i introduced the napa reauthorization act with senator warner, which would extend napa through 2035 and modernize the legislation to reflect the strides that have been made to better understand the disease such as including a new focus on promoting healthy aging, reducing risk factors and supporting family caregivers. the napa reauthorization act will allow the important work of the expert panel to continue through 2035. among its provisions, the bill would expand the council that assist annually in the development and evaluation of the national plan. it will